SCHEMBL7656160

SCHEMBL7656160

O=c1c(O)c(-c2ccc(O)c(O)c2)oc2ccc(NS(=O)(=O)c3ccc(F)cc3F)cc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.49
KMT2A Q03164 8/20 0.49
KDM4E B2RXH2 6/20 0.49
MAPT P10636 6/20 0.49
CYP3A4 P08684 5/20 0.49
CYP2C9 P11712 5/20 0.49
HSD17B10 Q99714 5/20 0.49
TP53 P04637 5/20 0.49
ALOX15 P16050 5/20 0.49
CDK2 P24941 4/20 0.49
RECQL P46063 4/20 0.49
ALOX12 P18054 3/20 0.49
MAPK1 P28482 3/20 0.49
CYP2D6 P10635 2/20 0.49
CYP2C19 P33261 2/20 0.49
ST6GAL1 P15907 1/20 0.49
CDK5 Q00535 3/20 0.46
CDK5R1 Q15078 3/20 0.46
AMY1A P0DUB6 3/20 0.46
ACHE P22303 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7663357 0.87 KDM4E (0.52) MEN1KMT2AKDM4EMAPTCYP3A4
SCHEMBL7657823 0.86 MEN1 (0.53) MEN1KMT2AKDM4EMAPTCYP3A4
SCHEMBL7658366 0.83 MEN1 (0.50) MEN1KMT2AKDM4EMAPTCYP3A4
SCHEMBL7655634 0.81 MEN1 (0.68) MEN1KMT2AKDM4EMAPTCYP3A4
SCHEMBL7660305 0.79 MEN1 (0.53) MEN1KMT2AKDM4EMAPTCYP3A4
SCHEMBL7660698 0.79 MAPT (0.58) MEN1KMT2AKDM4EMAPTCYP3A4
SCHEMBL7661882 0.79 MEN1 (0.52) MEN1KMT2AKDM4EMAPTCYP3A4
SCHEMBL7656155 0.79 ERAP1 (0.59) MEN1KMT2AKDM4EMAPTCYP3A4
SCHEMBL7659889 0.78 TDP1 (0.53) MEN1KMT2AKDM4EMAPTCYP3A4
SCHEMBL7657360 0.77 KDM4E (0.50) MEN1KMT2AKDM4EMAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6500846-B1 2-(4-CHLOROPHENYL)-7-METHOXYCHROMEN-4-ONE, AS CYCLIN-DEPENDENT KINASE INHIBITORS, USED AS ANTICARCINOGENIC AGENTS OR FOR PROPHYLAXIS OF NEURODEGENERATIVE DISEASE LG CHEMICAL, LTD. (KR) 2002-12-31 US claimed
EP-1109800-A1 NOVEL CDK INHIBITORS HAVING FLAVONE STRUCTURE LG CHEMICAL LIMITED (KR) 2001-06-27 EP claimed
WO-2000012496-A1 NOVEL CDK INHIBITORS HAVING FLAVONE STRUCTURE LG CHEMICAL LTD. (KR) 2000-03-09 WO claimed
US-6500846-B1 2-(4-CHLOROPHENYL)-7-METHOXYCHROMEN-4-ONE, AS CYCLIN-DEPENDENT KINASE INHIBITORS, USED AS ANTICARCINOGENIC AGENTS OR FOR PROPHYLAXIS OF NEURODEGENERATIVE DISEASE LG CHEMICAL, LTD. (KR) 2002-12-31 US disclosed
EP-1109800-A1 NOVEL CDK INHIBITORS HAVING FLAVONE STRUCTURE LG CHEMICAL LIMITED (KR) 2001-06-27 EP disclosed
WO-2000012496-A1 NOVEL CDK INHIBITORS HAVING FLAVONE STRUCTURE LG CHEMICAL LTD. (KR) 2000-03-09 WO disclosed